Tower Research Capital LLC (Trc) Atossa Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,644 shares of ATOS stock, worth $9,784. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,644
Previous 29,717 74.28%
Holding current value
$9,784
Previous $35,000 68.57%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1.09 - $1.52 $24,059 - $33,550
-22,073 Reduced 74.28%
7,644 $11,000
Q2 2024

Aug 13, 2024
BUY
$1.03 - $2.1 $30,607 - $62,403
29,716 Added 2971600.0%
29,717 $35,000
Q1 2024

May 15, 2024
SELL
$0.8 - $1.89 $8,598 - $20,313
-10,748 Reduced 99.99%
1 $0
Q4 2023

Feb 13, 2024
SELL
$0.63 - $0.98 $1,564 - $2,434
-2,484 Reduced 18.77%
10,749 $9,000
Q3 2023

Nov 14, 2023
SELL
$0.74 - $1.35 $2,627 - $4,793
-3,551 Reduced 21.16%
13,233 $9,000
Q2 2023

Aug 14, 2023
BUY
$0.6 - $1.28 $3,830 - $8,171
6,384 Added 61.38%
16,784 $21,000
Q1 2023

May 09, 2023
BUY
$0.59 - $0.91 $4,064 - $6,268
6,889 Added 196.21%
10,400 $8,000
Q4 2022

Feb 10, 2023
BUY
$0.5 - $1.01 $1,734 - $3,502
3,468 Added 8065.12%
3,511 $2,000
Q3 2022

Nov 10, 2022
SELL
$0.82 - $1.14 $1,072 - $1,491
-1,308 Reduced 96.82%
43 $0
Q2 2022

Aug 15, 2022
SELL
$0.85 - $1.28 $20,434 - $30,771
-24,040 Reduced 94.68%
1,351 $1,000
Q1 2022

May 12, 2022
BUY
$1.11 - $1.74 $3,364 - $5,273
3,031 Added 13.56%
25,391 $32,000
Q4 2021

Feb 14, 2022
BUY
$1.6 - $3.27 $23,673 - $48,382
14,796 Added 195.61%
22,360 $36,000
Q3 2021

Nov 15, 2021
BUY
$2.89 - $6.4 $8,025 - $17,772
2,777 Added 58.01%
7,564 $24,000
Q2 2021

Aug 16, 2021
BUY
$1.52 - $8.62 $7,276 - $41,263
4,787 New
4,787 $30,000
Q4 2020

Feb 16, 2021
SELL
$0.85 - $2.43 $1,037 - $2,964
-1,220 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$1.98 - $4.35 $902 - $1,983
-456 Reduced 27.21%
1,220 $3,000
Q2 2020

Aug 13, 2020
BUY
$1.04 - $4.05 $1,743 - $6,787
1,676 New
1,676 $6,000
Q3 2019

Nov 05, 2019
SELL
$1.96 - $2.52 $4,410 - $5,670
-2,250 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$2.03 - $3.58 $4,567 - $8,055
2,250 New
2,250 $6,000

Others Institutions Holding ATOS

# of Institutions
90
Shares Held
26.5M
Call Options Held
466K
Put Options Held
91.8K
View Full List

About ATOSSA THERAPEUTICS, INC.

ATOS Quotes by TradingView
  • Ticker ATOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,624,000
  • Market Cap $162M
  • Description
  • Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...
More about ATOS
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email